Sagespring Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.67M Buy
67,467
+1,152
+2% +$135K 0.13% 87
2026
Q1
$7.98M Sell
66,315
-160
-0.2% -$18.5K 0.15% 88
2025
Q4
$7M Buy
66,475
+19,946
+43% +$1.87M 0.13% 93
2025
Q3
$3.91M Buy
46,529
+13,778
+42% +$1.13M 0.08% 127
2025
Q2
$2.59M Sell
32,751
-10,958
-25% -$871K 0.06% 152
2025
Q1
$3.92M Sell
43,709
-9,254
-17% -$864K 0.1% 105
2024
Q4
$5.27M Buy
+52,963
New +$5.46M 0.14% 72

Other funds holding MRK

Sagespring Wealth Partners's MRK Position: Q2 2026 in Review

Sagespring Wealth Partners increased its Merck (MRK) stake by 1.7% in Q2 2026, buying an estimated $135K and bringing the position to 67,467 shares worth $8.67M. The position accounts for 0.13% of the portfolio, ranked #87.

Sagespring Wealth Partners first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sagespring Wealth Partners held 67,467 shares of Merck worth $8.67M as of Q2 2026.
  • Sagespring Wealth Partners bought 1,152 Merck shares in Q2 2026, an estimated $135K.
  • Merck made up 0.13% of Sagespring Wealth Partners's portfolio in Q2 2026, its #87 holding.
  • Sagespring Wealth Partners first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.